Immunosuppressants: Cellular and molecular mechanisms of action
- 1 August 1996
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 28 (2) , 159-172
- https://doi.org/10.1016/s0272-6386(96)90297-8
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory CompoundJournal of Biological Chemistry, 1995
- Leflunomide: An active antiinflammatory and antiproliferative agent in models of dermatologic diseaseInflammation Research, 1995
- Leflunomide interferes with pyrimidine nucleotide biosynthesisInflammation Research, 1995
- Signal transduction by lymphocyte antigen receptorsCell, 1994
- ANALYSES OF THE UNOS SCIENTIFIC RENAL TRANSPLANT REGISTRY AT THREE YEARS—EARLY EVENTS AFFECTING TRANSPLANT SUCCESS1–3Transplantation, 1992
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991
- Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal AllograftsNew England Journal of Medicine, 1990
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- ENHANCEMENT OF IMMUNOSUPPRESSION BY SUBSTITUTION OF FISH OIL FOR OLIVE OIL AS A VEHICLE FOR CYCLOSPORINETransplantation, 1989
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985